09:07:17 EDT Tue 22 Sep 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Cannabis Summary for Dec. 17, 2019

2019-12-17 21:24 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The Canadian Securities Exchange Composite Index dropped 12.72 points to 367.03 Tuesday, yet another 52-week low for the index. Yesterday, New Jersey lawmakers approved a resolution to put a referendum on legalizing marijuana on the state's 2020 ballot. The resolution was approved by a supermajority (at least three-fifths of the vote), which, according to CBS News, means lawmakers will not have to vote again next year. The ballot will be held next November.

Florida-based Trulieve Cannabis Corp. (TRUL) sank $2.02 to $13.67 on 5.62 million shares after the release of a short-seller report this morning from an outfit called Grizzly Research LLC. It is full of allegations damaging to Trulieve, its management and its products.

Trulieve, as well as analysts, quickly responded to the report, saying that it contains "several false, slanderous and misleading statements about Trulieve." Trulieve said that it intends to pursue legal action against Grizzly, noting that Grizzly has no history or credibility in assessing cannabis companies. In fact, Trulieve has a reputation as one of the very few companies in the industry that is operating efficiently, with the result that it has not been hit as hard as most. It is down from a 52-week high of $21.65 and even with today's drop, its closing price of $13.67 is still above its Jan. 1 price of $11.12. With its focus almost entirely on the Floridian market (41 of its 43 dispensaries are in Florida), Trulieve's results have continued to improve in 2019. The U.S.-based retailer had $44.4-million (U.S.) in net revenue in Q1, $57.9-million (U.S.) in Q2 and $70.7-million (U.S.) in Q3.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2020 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.